SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-18-009148
Filing Date
2018-02-14
Accepted
2018-02-13 19:27:24
Documents
1
Group Members
BONG KOHNIMISH SHAHVENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5196_4sc13ga.htm SC 13G/A 345429
  Complete submission text file 0001104659-18-009148.txt   347250
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44055 | Film No.: 18606154
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650-475-3734
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A